0000899243-22-038096.txt : 20221209 0000899243-22-038096.hdr.sgml : 20221209 20221209164239 ACCESSION NUMBER: 0000899243-22-038096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221207 FILED AS OF DATE: 20221209 DATE AS OF CHANGE: 20221209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Olagunju Peter CENTRAL INDEX KEY: 0001875057 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38811 FILM NUMBER: 221455332 MAIL ADDRESS: STREET 1: TCR2 THERAPEUTICS INC. STREET 2: 100 BINNEY STREET, SUITE 710 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC. CENTRAL INDEX KEY: 0001750019 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474152751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-5200 MAIL ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-07 0 0001750019 TCR2 THERAPEUTICS INC. TCRR 0001875057 Olagunju Peter C/O TCR2 THERAPEUTICS 100 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Technical Officer Common Stock 31710 D Common Stock 2022-12-07 4 S 0 1378 1.282 D 30332 D Common Stock 2022-12-08 4 S 0 1410 1.253 D 28922 D The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1. /s/ Margaret Siegel as Attorney-in-Fact 2022-12-09